MIF and central nervous system cancer: Other Authors have reported that stable knockdown of MIF by shRNA in glioma cells increased tumour cell susceptibility towards NK cell- and CD8+T cell- mediated cytotoxicity by downregulating the immune receptor NKG2D on NK and CD8+ T cells [83].